It has been a good week for positive news vis-à-vis vaccines for COVID-19 in India and outside. In India, two vaccine candidates of two pharmaceutical companies entered a crucial human trial phase this week . A company, in an official statement today, said that its vaccine candidate, COVID vaccine, has entered the human trial stage. “The Adaptive Phase I/ II human clinical trials of its plasmid DNA vaccine, COVID vaccine commenced today with the first human dosing.
The Adaptive Phase I/II dose-escalation, multi-centric study will assess the safety, tolerability, and immunogenicity of the vaccine” the company said. Chairman of the pharma company said, “This is an all-important step in our fight against COVID-19.” COVID vaccine was found to be safe, immunogenic, well-tolerated in the pre-clinical toxicity studies. The vaccine was able to elicit a high level of neutralizing antibodies in…
